Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1997 1
2002 1
2004 6
2005 4
2006 4
2007 1
2008 1
2010 1
2011 1
2012 1
2013 1
2017 1
2018 1
2019 1
2020 2
2021 5
2022 2
2023 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series.
Messina E, Danise A, Ferrari G, Andolina A, Chiurlo M, Razanakolona M, Barakat M, Israel RJ, Castagna A. Messina E, et al. Among authors: danise a. Infect Dis Ther. 2021 Dec;10(4):2791-2804. doi: 10.1007/s40121-021-00493-9. Epub 2021 Jul 23. Infect Dis Ther. 2021. PMID: 34302258 Free PMC article.
SARS-CoV-2 Pneumonia in a Manic Inpatient: Implications in Clinical Care.
Sarzetto A, Mazzi F, Albano G, Bottanelli M, Franchini L, Danise A, Colombo C. Sarzetto A, et al. Among authors: danise a. Prim Care Companion CNS Disord. 2021 Nov 18;23(6):21cr03099. doi: 10.4088/PCC.21cr03099. Prim Care Companion CNS Disord. 2021. PMID: 34797963 Free article. No abstract available.
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia: A Randomized Clinical Trial.
Menichetti F, Popoli P, Puopolo M, Spila Alegiani S, Tiseo G, Bartoloni A, De Socio GV, Luchi S, Blanc P, Puoti M, Toschi E, Massari M, Palmisano L, Marano G, Chiamenti M, Martinelli L, Franchi S, Pallotto C, Suardi LR, Luciani Pasqua B, Merli M, Fabiani P, Bertolucci L, Borchi B, Modica S, Moneta S, Marchetti G, d'Arminio Monforte A, Stoppini L, Ferracchiato N, Piconi S, Fabbri C, Beccastrini E, Saccardi R, Giacometti A, Esperti S, Pierotti P, Bernini L, Bianco C, Benedetti S, Lanzi A, Bonfanti P, Massari M, Sani S, Saracino A, Castagna A, Trabace L, Lanza M, Focosi D, Mazzoni A, Pistello M, Falcone M; TSUNAMI Study group. Menichetti F, et al. JAMA Netw Open. 2021 Nov 1;4(11):e2136246. doi: 10.1001/jamanetworkopen.2021.36246. JAMA Netw Open. 2021. PMID: 34842924 Free PMC article. Clinical Trial.
Fever of unknown origin (FUO) FADOI-SIMIT Italian registry: can demographics, comorbidities, and clinical variables predict the etiology of classic FUO?-a prospective Italian study.
Luzzati R, Zerbato V, Attard L, Virgili G, Cilli A, Zanier A, Libanore M, Segala D, Tedesco A, Bortolotti ME, Pontali E, Feasi M, Re A, Giarretta I, Pomero F, Zagarrì E, Concia E, Dentali F, Manfellotto D, Campanini M; FADOI-FUO Study Group. Luzzati R, et al. Intern Emerg Med. 2025 Aug 19. doi: 10.1007/s11739-025-04084-1. Online ahead of print. Intern Emerg Med. 2025. PMID: 40828443
The INfectious DIsease REgistry BIObank (INDI-REBIO): protocol for the design and implementation of a single-centre, prospective registry and biobank in a tertiary care centre in Italy for advancing infectious disease research.
Ripa M, Galli L, Cinque P, Nozza S, Spagnuolo V, Tassan Din C, Guffanti M, Lolatto R, Piromalli G, Carletti S, Locatelli M, Sanvito F, Ponzoni M, Cantarelli E, Tresoldi C, Castagna A; INDI-REBIO Study Group. Ripa M, et al. BMJ Open. 2025 Aug 12;15(8):e091113. doi: 10.1136/bmjopen-2024-091113. BMJ Open. 2025. PMID: 40803735 Free PMC article.
37 results